glp-1 substance use disorder Anti-Obesity Rx and Alcohol and Disorders GLP-1 Drugs and Eating Disorders:

Relation to Neuroprotection: Such synthetic substances bind to GLP-1 receptors in the cortex, hippocampus, amygdala, and basal ganglia, triggering the following signal transduction: Switching off inflammatory NF-B downstream pathways like cytokines (IL-1/IL-6) and tumor necrosis factor (TNF-)

Participants frequently reported stigma associated with using weight-loss medications

Semaglutide is an FDA-approved GLP-1 medication that helps regulate appetite, reduce cravings, and improve fullness signals

J Clin Periodontol

Its hard to know if those higher doses of oral semaglutide would show different performance, she says